Please download the dossier by clicking on the dossier button x
×

RECOMBINANT ANTIBODIES THAT RECONGNIZE THE C-TERMINAL DOMAINS OF EBOLA VIRUS NUCLEOPROTEIN

  • US 20180334494A1
  • Filed: 10/16/2015
  • Published: 11/22/2018
  • Est. Priority Date: 10/17/2014
  • Status: Active Grant
First Claim
Patent Images

1. An antibody that specifically binds to the Nucleoprotein of Ebola virus, or a binding fragment thereof, wherein said antibody comprises complementarity determining region (CDR) sequences selected from one of the following sets:

  • a) SEQ ID NO;

    57, SEQ ID NO;

    34, SEQ ID NO;

    121, and SEQ ID NO;

    35;

    b) SEQ ID NO;

    127, SEQ ID NO;

    128, SEQ ID NO;

    126, and SEQ ID NO;

    129;

    c) SEQ ID NO;

    63, SEQ ID NO;

    131, SEQ ID NO;

    130, and SEQ ID NO;

    132;

    d) SEQ ID NO;

    43, SEQ ID NO;

    96, SEQ ID NO;

    145, and SEQ ID NO;

    35;

    e) SEQ ID NO;

    95, SEQ ID NO;

    96, SEQ ID NO;

    94, and SEQ ID NO;

    97; and

    f) SEQ ID NO;

    105, SEQ ID NO;

    51, SEQ ID NO;

    104, and SEQ ID NO;

    106.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×